AKTX

Akari Therapeutics plc ADS (AKTX)

About Akari Therapeutics plc ADS (AKTX)

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Boston, MA.

Details

Daily high

$2.99

Daily low

$2.52

Price at open

$2.68

52 Week High

$4.40

52 Week Low

$1.08

Market cap

32.8M

Dividend yield

0.00%

Volume

9,862

Avg. volume

19,756

P/E ratio

-.39

Akari Therapeutics plc ADS News